Early cholesterol treatment after a heart attack
Treatments studied
Part of Heart & circulation, Hormones & metabolism, Pain clinical trials.
This study tests whether adding an extra cholesterol-lowering drug (bempedoic acid) to the usual treatment soon after a heart attack or related event can lower 'bad' cholesterol more effectively. It may help reduce the risk of future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a heart attack or unstable angina, and had a balloon/stent procedure (angioplasty) in the last 72 hours.
- Your 'bad' cholesterol (LDL) is at least 70 mg/dL.
- You are not currently taking PCSK9 inhibitors or fibrates for cholesterol.
- You do not have gout, severe liver or kidney disease, or gallbladder problems.
- You are not pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a medication called bempedoic acid to standard cholesterol-lowering pills is better at lowering cholesterol after a heart attack. If you have recently had a heart attack and are already on statins, this might be an option to help prevent future heart problems.
This study tests an educational program to help people understand and lower their LDL ('bad') cholesterol after a heart-related event. It aims to improve awareness and encourage the use of cholesterol-lowering treatments.
This study tests whether starting strong cholesterol-lowering treatment early in the hospital can improve outcomes for people with acute coronary syndrome (a serious heart condition like a heart attack or unstable angina). It may help if you have high LDL cholesterol.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
This study tests whether a newer cholesterol-lowering injection, given early after a heart attack, helps keep the plaque in your arteries stable and reduces future risk. It compares the new medicine added to your usual statin treatment.
This study tests whether giving a strong cholesterol-lowering treatment right after a heart attack helps reduce the chance of future heart problems. It's for people who are not already on cholesterol medications.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.